First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) — Net Asset Quality Index
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has a Net Asset Quality Index of 88.6% as of December 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $441.89 Million minus total liabilities of $50.30 Million yields net assets of $391.60 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check TRAXV asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Net Asset Quality Index Over Time (2023–2024)
This chart shows how First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued's Net Asset Quality Index has evolved across 2 annual periods from 2023 to 2024. As of December 2024, the index stands at 88.6%, representing net assets of $391.60 Million against total assets of $441.89 Million USD. See TRAXV working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (2023–2024)
The table below presents the year-by-year Net Asset Quality Index for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued from 2023 to 2024, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see TRAXV stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 88.6% | $391.60 Million | $441.89 Million | $50.30 Million | ▼ -3.7 pp |
| 2023 | 92.3% | $409.85 Million | $444.11 Million | $34.26 Million | — |